Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus versus beclomethasone suppositories for refractory or recurrent ulcerative proctitis
NL-OMON47129Phase 3Recruiting
- Sponsor
- Erasmus MC
- Start
- Feb 2014
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in ulcerative proctitis comparing Tacrolimus suppositories with Beclomethasone suppositories (2 arms). Primary endpoint: Clinical response at day 28. Started Feb 2014; status: recruiting.
02
Drugs
tacrolimusbeclomethasone
03
Conditions
ulcerative proctitis
Beyond the preview
Go deeper on NL-OMON47129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47129.